The tumor was confirmed by NGS to harbor a novel PEAR1-NTRK1 fusion with the 5′ end of NTRK1, including the kinase domain, starting at exon 9 fused to exon 15 of PEAR1 (Figure 2(c)). Here, PEAR1 is linked to neoplasm.